0001552470-14-000001.txt : 20140625 0001552470-14-000001.hdr.sgml : 20140625 20140625163820 ACCESSION NUMBER: 0001552470-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20140625 DATE AS OF CHANGE: 20140625 EFFECTIVENESS DATE: 20140625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reviva Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001552470 IRS NUMBER: 204907893 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-219817 FILM NUMBER: 14940336 BUSINESS ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 BUSINESS PHONE: 408-960-2209 MAIL ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 D 1 primary_doc.xml X0707 D LIVE 0001552470 Reviva Pharmaceuticals, Inc. 5941 OPTICAL COURT SAN JOSE CA CALIFORNIA 95138 408-960-2209 DELAWARE None None Corporation true Laxminarayan Bhat 5941 Optical Court,Suite 215 San Jose CA CALIFORNIA 95138 Executive Officer Director Pharmaceuticals Decline to Disclose 06c false 2014-06-12 false true true Conversion of Promissory Notes to Series 4 Preferred Stock false 0 15831541 15831541 0 false 47 0 0 0 false Reviva Pharmaceuticals, Inc. Laxminarayan Bhat Laxminarayan Bhat President & CEO 2014-06-25